Quercetin: The Widely Studied Flavonoid Behind Allergies, Immunity, Cardiovascular Health, and Longevity

Quercetin is one of the most abundant flavonoids in the human diet, present in onions (especially red onions and shallots), capers, apples, red wine, black and green tea, berries, broccoli, kale, and citrus peels. It has been studied for decades as a natural antihistamine, an anti-inflammatory, a cardiovascular protectant, and more recently as a senolytic agent used in combination with the cancer drug dasatinib in early human trials of age-related disease.

This article covers the core biology of quercetin, what the strongest human evidence shows, dosing considerations, the partnership with dasatinib in senolytic trials, and why quercetin has remained one of the most relevant polyphenols in the longevity toolkit.

Table of Contents

  1. Structure and Food Sources
  2. Antihistamine and Allergy Effects
  3. Antiviral and Immune Effects
  4. Cardiovascular Benefits
  5. Senolytic Use with Dasatinib
  6. Quercetin as a Zinc Ionophore
  7. Forms, Dosing, and Bioavailability
  8. Safety and Interactions
  9. Connections

Structure and Food Sources

Quercetin belongs to the flavonol subclass of flavonoids and is typically found in plants bound to sugars as glycosides (e.g., rutin, isoquercitrin). The richest dietary sources are:

Antihistamine and Allergy Effects

Quercetin stabilizes mast-cell membranes, reducing the release of histamine and other mediators that drive allergic rhinitis, urticaria, and some asthma phenotypes. Randomized trials have shown reductions in nasal-allergy symptom scores; clinical effect sizes are modest but meaningful for people seeking non-sedating natural options. It pairs well with vitamin C, which helps recycle oxidized quercetin.

Antiviral and Immune Effects

Quercetin has shown antiviral activity against a wide range of respiratory viruses in laboratory studies, operating in part through inhibition of viral entry and replication enzymes. Human-trial evidence is mixed but suggestive of shorter symptom duration when used prophylactically during viral-heavy seasons. It also modulates immune function by shifting T-cell balance and reducing excessive NF-κB-driven inflammation.

Cardiovascular Benefits

Meta-analyses of randomized trials show quercetin (typically 500–1000 mg/day for 8–12 weeks) lowers systolic blood pressure by roughly 3–5 mmHg — a clinically relevant signal, particularly in people with metabolic syndrome or hypertension. Additional benefits include improved endothelial function, reduced LDL oxidation, and modest lipid improvements. The large dietary-flavonol epidemiological literature consistently associates high intake with lower cardiovascular mortality.

Senolytic Use with Dasatinib

The Mayo Clinic team that later identified fisetin first developed the Dasatinib + Quercetin (D+Q) cocktail as a proof-of- concept senolytic regimen. A single 2–3 day pulsed course of the combination reduced senescent-cell burden in aged mice and in human patients with diabetic kidney disease. D+Q trials continue in idiopathic pulmonary fibrosis, diabetic kidney disease, and frailty. Quercetin alone has weaker senolytic activity than D+Q or fisetin, but it remains the accessible, food-derived half of the pair.

Quercetin as a Zinc Ionophore

Quercetin enhances intracellular delivery of zinc by acting as a zinc ionophore. Zinc itself has antiviral activity and supports immune function; the combination of quercetin plus zinc is a common integrative-medicine cold/flu protocol for this reason. This shuttling mechanism is shared with the nutraceutical ionophore epigallocatechin gallate (EGCG) found in green tea.

Forms, Dosing, and Bioavailability

Plain quercetin aglycone has poor bioavailability. Enhanced forms include:

Typical daily doses: 250–1000 mg/day for cardiovascular and allergy outcomes, split across meals. Senolytic pulsed protocols use higher short-course doses. Take with a fat-containing meal.

Safety and Interactions

Connections

↑ Back to Table of Contents